Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 98
Filtrar
1.
ACS Synth Biol ; 13(5): 1562-1571, 2024 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-38679882

RESUMEN

Respirantins are 18-membered antimycin-type depsipeptides produced by Streptomyces sp. and Kitasatospora sp. These compounds have shown extraordinary anticancer activities against a panel of cancer cell lines with nanomolar levels of IC50 values. However, further investigation has been impeded by the low titers of the natural producers and the challenging chemical synthesis due to their structural complexity. The biosynthetic gene cluster (BGC) of respirantin was previously proposed based on a bioinformatic comparison of the four members of antimycin-type depsipeptides. In this study, we report the first successful reconstitution of respirantin in Streptomyces albus using a synthetic BGC. This heterologous system serves as an accessible platform for the production and diversification of respirantins. Through polyketide synthase pathway engineering, biocatalysis, and chemical derivatization, we generated nine respirantin compounds, including six new derivatives. Cytotoxicity screening against human MCF-7 and Hela cancer cell lines revealed a unique biphasic dose-response profile of respirantin. Furthermore, a structure-activity relationship study has elucidated the essential functional groups that contribute to its remarkable cytotoxicity. This work paves the way for respirantin-based anticancer drug discovery and development.


Asunto(s)
Antimicina A , Antineoplásicos , Depsipéptidos , Familia de Multigenes , Streptomyces , Humanos , Streptomyces/metabolismo , Streptomyces/genética , Depsipéptidos/farmacología , Depsipéptidos/química , Depsipéptidos/biosíntesis , Antineoplásicos/farmacología , Antineoplásicos/metabolismo , Antineoplásicos/química , Células HeLa , Antimicina A/análogos & derivados , Antimicina A/farmacología , Antimicina A/metabolismo , Células MCF-7 , Sintasas Poliquetidas/metabolismo , Sintasas Poliquetidas/genética , Vías Biosintéticas/genética , Relación Estructura-Actividad
2.
Virology ; 590: 109943, 2024 02.
Artículo en Inglés | MEDLINE | ID: mdl-38103268

RESUMEN

The Ibaraki virus (IBAV) causes Ibaraki disease in cattle. Our previous studies have shown that IBAV uses macropinocytosis to enter the host cell and exit from the endosome to the cytosol in response to endosomal acidification. To further explore the mechanism of IBAV infection and replication, we examined the effect of inhibitors of mitochondrial oxidative phosphorylation, carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and antimycin A, on IBAV propagation. These inhibitors significantly suppressed IBAV propagation, with reduced cellular ATP levels resulting from suppression of ATP synthesis. Furthermore, we identified AMP-activated protein kinase (AMPK), which is activated by CCCP or antimycin A, as a key signaling molecule in IBAV suppression. We also observed that IBAV infection induces ATP depletion and increases AMPK activity. Our findings suggest that AMPK is a potential target in Ibaraki disease.


Asunto(s)
Proteínas Quinasas Activadas por AMP , Mitocondrias , Animales , Bovinos , Proteínas Quinasas Activadas por AMP/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Antimicina A/metabolismo , Carbonil Cianuro m-Clorofenil Hidrazona/metabolismo , Carbonil Cianuro m-Clorofenil Hidrazona/farmacología , Mitocondrias/metabolismo , Adenosina Trifosfato/metabolismo
3.
Mol Biol (Mosk) ; 57(4): 689-691, 2023.
Artículo en Ruso | MEDLINE | ID: mdl-37528789

RESUMEN

Ras proteins are small GTPases and function as molecular switches to regulate cellular homeostasis. Ras-dependent signalling pathways regulate several essential processes such as cell cycle progression, growth, migration, apoptosis, and senescence. The dysregulation of Ras signaling pathway has been linked to several pathological outcomes. A potential role of RAS in regulating the redox signalling pathway has been established that includes the manipulation of ROS levels to provide a redox milieu that might be conducive to carcinogenesis. Reactive oxygen species (ROS) and mitochondrial impairment have been proposed as major factors affecting the physiology of cells and implicated in several pathologies. The present study was conducted to evaluate the role of Ras1, tert Butyl hydroperoxide (tBHP), and antimycin A in oxidative stress response in Schizosaccharomyces pombe cells. We observed decreased cell survival, higher levels of ROS, and mitochondrial dysfunctionality in ras1Δ cells and tBHP as well as respiratory inhibitor, antimycin A treated wild type cells. Furthermore, these defects were more profound in ras1Δ cells treated with tBHP or antimycin A. Additionally, Ras1 also has been shown to regulate the expression and activity of several antioxidant enzymes like glutathione peroxidase (GSH-Px), glutathione-S-transferase (GST), and catalase. Together, these results suggest the potential role of S. pombe Ras1 in mitigating oxidative stress response.


Asunto(s)
Schizosaccharomyces , Especies Reactivas de Oxígeno/metabolismo , terc-Butilhidroperóxido/toxicidad , terc-Butilhidroperóxido/metabolismo , Schizosaccharomyces/genética , Schizosaccharomyces/metabolismo , Antimicina A/farmacología , Antimicina A/metabolismo , Estrés Oxidativo , Oxidación-Reducción
4.
Curr Neuropharmacol ; 21(5): 1026-1041, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36918785

RESUMEN

With the advancement in novel drug discovery, biologically active compounds are considered pharmacological tools to understand complex biological mechanisms and the identification of potent therapeutic agents. Mitochondria boast a central role in different integral biological processes and mitochondrial dysfunction is associated with multiple pathologies. It is, therefore, prudent to target mitochondrial quality control mechanisms by using pharmacological approaches. However, there is a scarcity of biologically active molecules, which can interact with mitochondria directly. Currently, the chemical compounds used to induce mitophagy include oligomycin and antimycin A for impaired respiration and acute dissipation of mitochondrial membrane potential by using CCCP/FCCP, the mitochondrial uncouplers. These chemical probes alter the homeostasis of the mitochondria and limit our understanding of the energy regulatory mechanisms. Efforts are underway to find molecules that can bring about selective removal of defective mitochondria without compromising normal mitochondrial respiration. In this report, we have tried to summarize and status of the recently reported modulators of mitophagy.


Asunto(s)
Mitocondrias , Mitofagia , Humanos , Mitofagia/fisiología , Mitocondrias/metabolismo , Potencial de la Membrana Mitocondrial , Antimicina A/metabolismo
5.
Autophagy ; 19(5): 1444-1458, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-36217215

RESUMEN

Macroautophagy/autophagy or mitophagy plays crucial roles in the maintenance of pancreatic ß-cell function. PPP3/calcineurin can modulate the activity of TFEB, a master regulator of lysosomal biogenesis and autophagy gene expression, through dephosphorylation. We studied whether PPP3/calcineurin inhibitors can affect the mitophagy of pancreatic ß-cells and pancreatic ß-cell function employing FK506, an immunosuppressive drug against graft rejection. FK506 suppressed rotenone- or oligomycin+antimycin-A-induced mitophagy measured by Mito-Keima localization in acidic lysosomes or RFP-LC3 puncta colocalized with TOMM20 in INS-1 insulinoma cells. FK506 diminished nuclear translocation of TFEB after treatment with rotenone or oligomycin+antimycin A. Forced TFEB nuclear translocation by a constitutively active TFEB mutant transfection restored impaired mitophagy by FK506, suggesting the role of decreased TFEB nuclear translocation in FK506-mediated mitophagy impairment. Probably due to reduced mitophagy, recovery of mitochondrial potential or quenching of mitochondrial ROS after removal of rotenone or oligomycin+antimycin A was delayed by FK506. Mitochondrial oxygen consumption was reduced by FK506, indicating reduced mitochondrial function by FK506. Likely due to mitochondrial dysfunction, insulin release from INS-1 cells was reduced by FK506 in vitro. FK506 treatment also reduced insulin release and impaired glucose tolerance in vivo, which was associated with decreased mitophagy and mitochondrial COX activity in pancreatic islets. FK506-induced mitochondrial dysfunction and glucose intolerance were ameliorated by an autophagy enhancer activating TFEB. These results suggest that diminished mitophagy and consequent mitochondrial dysfunction of pancreatic ß-cells contribute to FK506-induced ß-cell dysfunction or glucose intolerance, and autophagy enhancement could be a therapeutic modality against post-transplantation diabetes mellitus caused by PPP3/calcineurin inhibitors.


Asunto(s)
Intolerancia a la Glucosa , Insulinas , Humanos , Mitofagia/genética , Autofagia/fisiología , Inhibidores de la Calcineurina/metabolismo , Tacrolimus/farmacología , Tacrolimus/metabolismo , Antimicina A/metabolismo , Intolerancia a la Glucosa/metabolismo , Rotenona , Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice/metabolismo , Lisosomas/metabolismo , Oligomicinas/metabolismo , Insulinas/metabolismo
6.
Int J Mol Sci ; 23(20)2022 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-36293550

RESUMEN

Trained immune responses, based on metabolic and epigenetic changes in innate immune cells, are de facto innate immune memory and, therefore, are of great interest in vaccine development. In previous studies, the recombinant fusion protein rFlaA:Betv1, combining the adjuvant and toll-like receptor (TLR)5-ligand flagellin (FlaA) and the major birch pollen allergen Bet v 1 into a single molecule, significantly suppressed allergic sensitization in vivo while also changing the metabolism of myeloid dendritic cells (mDCs). Within this study, the immune-metabolic effects of rFlaA:Betv1 during mDC activation were elucidated. In line with results for other well-characterized TLR-ligands, rFlaA:Betv1 increased glycolysis while suppressing oxidative phosphorylation to different extents, making rFlaA:Betv1 a suitable model to study the immune-metabolic effects of TLR-adjuvanted vaccines. In vitro pretreatment of mDCs with cerulenin (inhibitor of fatty acid biosynthesis) led to a decrease in both rFlaA:Betv1-induced anti-inflammatory cytokine Interleukin (IL) 10 and T helper cell type (TH) 1-related cytokine IL-12p70, while the pro-inflammatory cytokine IL 1ß was unaffected. Interestingly, pretreatment with the glutaminase inhibitor BPTES resulted in an increase in IL-1ß, but decreased IL-12p70 secretion while leaving IL-10 unchanged. Inhibition of the glycolytic enzyme hexokinase-2 by 2-deoxyglucose led to a decrease in all investigated cytokines (IL-10, IL-12p70, and IL-1ß). Inhibitors of mitochondrial respiration had no effect on rFlaA:Betv1-induced IL-10 level, but either enhanced the secretion of IL-1ß (oligomycin) or decreased IL-12p70 (antimycin A). In extracellular flux measurements, mDCs showed a strongly enhanced glycolysis after rFlaA:Betv1 stimulation, which was slightly increased after respiratory shutdown using antimycin A. rFlaA:Betv1-stimulated mDCs secreted directly antimicrobial substances in a mTOR- and fatty acid metabolism-dependent manner. In co-cultures of rFlaA:Betv1-stimulated mDCs with CD4+ T cells, the suppression of Bet v 1-specific TH2 responses was shown to depend on fatty acid synthesis. The effector function of rFlaA:Betv1-activated mDCs mainly relies on glycolysis, with fatty acid synthesis also significantly contributing to rFlaA:Betv1-mediated cytokine secretion, the production of antimicrobial molecules, and the modulation of T cell responses.


Asunto(s)
Receptor Toll-Like 5 , Vacunas , Receptor Toll-Like 5/metabolismo , Alérgenos , Interleucina-10/metabolismo , Flagelina/metabolismo , Hexoquinasa/metabolismo , Glutaminasa/metabolismo , Ligandos , Antimicina A/metabolismo , Antimicina A/farmacología , Cerulenina/metabolismo , Cerulenina/farmacología , Células Dendríticas , Proteínas Recombinantes/metabolismo , Citocinas/metabolismo , Adyuvantes Inmunológicos/farmacología , Vacunas/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Glucólisis , Serina-Treonina Quinasas TOR/metabolismo , Desoxiglucosa/farmacología , Oligomicinas/farmacología , Ácidos Grasos/metabolismo
7.
Biochemistry (Mosc) ; 87(8): 720-730, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36171653

RESUMEN

Cytochrome bd-II is one of the three terminal quinol oxidases of the aerobic respiratory chain of Escherichia coli. Preparations of the detergent-solubilized untagged bd-II oxidase isolated from the bacterium were shown to scavenge hydrogen peroxide (H2O2) with high rate producing molecular oxygen (O2). Addition of H2O2 to the same buffer that does not contain enzyme or contains thermally denatured cytochrome bd-II does not lead to any O2 production. The latter observation rules out involvement of adventitious transition metals bound to the protein. The H2O2-induced O2 production is not susceptible to inhibition by N-ethylmaleimide (the sulfhydryl binding compound), antimycin A (the compound that binds specifically to a quinol binding site), and CO (diatomic gas that binds specifically to the reduced heme d). However, O2 formation is inhibited by cyanide (IC50 = 4.5 ± 0.5 µM) and azide. Addition of H2O2 in the presence of dithiothreitol and ubiquinone-1 does not inactivate cytochrome bd-II and apparently does not affect the O2 reductase activity of the enzyme. The ability of cytochrome bd-II to detoxify H2O2 could play a role in bacterial physiology by conferring resistance to the peroxide-mediated stress.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa , Proteínas de Escherichia coli , Escherichia coli , Antimicina A/metabolismo , Azidas/metabolismo , Proteínas de la Membrana Bacteriana Externa/metabolismo , Cianuros/metabolismo , Grupo Citocromo b/metabolismo , Citocromos/metabolismo , Detergentes , Ditiotreitol/metabolismo , Proteínas del Complejo de Cadena de Transporte de Electrón/metabolismo , Escherichia coli/metabolismo , Proteínas de Escherichia coli/metabolismo , Etilmaleimida/metabolismo , Peróxido de Hidrógeno/metabolismo , Hidroquinonas/metabolismo , Oxidación-Reducción , Oxidorreductasas/metabolismo , Oxígeno/metabolismo , Ubiquinona/metabolismo
8.
Toxicol In Vitro ; 83: 105407, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35659575

RESUMEN

INTRODUCTION: Commercially-available resazurin-based reagents used for cell viability assessment contain varying amounts of resorufin; these may contribute to differences in autofluorescence, signal-to-background (S/B) ratio and the dynamic range of the assay. OBJECTIVES: This in vitro study compares the sensitivity of a new, high-sensitivity PrestoBlue (hs-PB) assay with standard PrestoBlue (PB) in assessing the efficacy of valinomycin and antimycin A in human vascular endothelial EA.hy926 cells, as well as cell viability. METHODS: The metabolic activity of EA.hy926 was evaluated based on resorufin fluorescence (PB assays) or formazan absorbance (MTT assay). RESULTS: The hs-PB assay demonstrated lower resorufin autofluorescence than the PB, resulting in a ≥ 1.4-fold increase in S/B ratio in hs-PB compared to PB. Valinomycin was more potent cytotoxic agent than antimycin A. The hs-PB, PB and MTT produced similar IC50 values for valinomycin. Antimycin A showed significantly higher potency in the MTT than in the resazurin-based assays. The EA.hy926 cells demonstrated higher metabolic activity in the presence of the antimycin A solvent - DMSO. CONCLUSION: All the examined methods may be used interchangeably to analyze drug cytotoxicity. Any differences in drug cytotoxicity observed between the assays may be due to relatively low drug potency and/or the influence of solvent on metabolism of assay reagent. The hs-PB assay appears to more effectively detect cell viability and produce a stronger signal than its conventional counterpart.


Asunto(s)
Células Endoteliales , Antimicina A/metabolismo , Antimicina A/toxicidad , Supervivencia Celular , Humanos , Indicadores y Reactivos/farmacología , Solventes/farmacología , Valinomicina/metabolismo , Valinomicina/farmacología
9.
Arch Biochem Biophys ; 726: 109232, 2022 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-35660297

RESUMEN

Much evidence indicates that superoxide is generated from O2 in a cyanide-sensitive reaction involving a reduced component of complex III of the mitochondrial respiratory chain, particularly when antimycin A is present. Although it is generally believed that ubisemiquinone is the electron donor to O2, little experimental evidence supporting this view has been reported. Experiments with succinate as electron donor in the presence of antimycin A in intact rat heart mitochondria, which contain much superoxide dismutase but little catalase, showed that myxothiazol, which inhibits reduction of the Rieske iron-sulfur center, prevented formation of hydrogen peroxide, determined spectrophotometrically as the H2O2-peroxidase complex. Similarly, depletion of the mitochondria of their cytochrome c also inhibited formation of H2O2, which was restored by addition of cytochrome c. These observations indicate that factors preventing the formation of ubisemiquinone also prevent H2O2 formation. They also exclude ubiquinol, which remains reduced under these conditions, as the reductant of O2. Since cytochrome b also remains fully reduced when myxothiazol is added to succinate- and antimycin A-supplemented mitochondria, reduced cytochrome b may also be excluded as the reductant of O2. These observations, which are consistent with the Q-cycle reactions, by exclusion of other possibilities leave ubisemiquinone as the only reduced electron carrier in complex III capable of reducing O2 to O2-.


Asunto(s)
Mitocondrias Cardíacas , Superóxidos , Animales , Antimicina A/metabolismo , Antimicina A/farmacología , Citocromos b/metabolismo , Citocromos c/metabolismo , Transporte de Electrón , Complejo III de Transporte de Electrones/metabolismo , Electrones , Peróxido de Hidrógeno/metabolismo , Mitocondrias Cardíacas/metabolismo , Oxidación-Reducción , Ratas , Sustancias Reductoras/metabolismo , Succinatos/metabolismo , Succinatos/farmacología , Ácido Succínico , Superóxidos/metabolismo , Ubiquinona/análogos & derivados
10.
Chem Biol Interact ; 360: 109937, 2022 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-35430258

RESUMEN

Transplantation of mesenchymal stem cells (MSCs) is an effective treatment in tissue injuries though it is limited due to the early death of stem cells within the first few days. The main reason could be a deficiency in the respiratory chain of injured tissues which is linked to the oxidative stress (OS) and disruption of energy metabolism. The disruption in energy metabolism and OS both inhibit the homing of stem cells in the hypoxic micro-environment, however on other hand, the key functions of stem cells are mainly regulated by their cellular redox status and energy metabolism. Because of that, strategies are being developed to improve the bio-functional properties of MSCs, including preconditioning of the stem cells in hypoxic conditions and pretreatment of antioxidants. To achieve this purpose, in this study N-acetylcysteine (NAC) was used for the protection of cells from oxidative stress and the disruption in energy metabolism was induced by Antimycin A (AMA) via blocking the cytochrome C complex. Then several parameters were analyzed, including cell viability/apoptosis, mitochondrial membrane potential, and redox molecular homeostasis. Based on our findings, upon the exposure of the MSCs to the conditions of deficient respiratory chain, the cells failed to scavenge the free radicals, and energy metabolism was disrupted. The use of NAC was found to alleviate the DNA damage, cell apoptosis, and oxidative stress via Nrf2/Sirt3 pathway though without any effect on the mitochondrial membrane potential. It means that antioxidants protect the cells from OS but the problem of ATP metabolism yet remains unresolved in the hypoxic conditions.


Asunto(s)
Células Madre Mesenquimatosas , Enfermedades Mitocondriales , Acetilcisteína/farmacología , Antimicina A/metabolismo , Antimicina A/farmacología , Antioxidantes/metabolismo , Antioxidantes/farmacología , Apoptosis , Humanos , Enfermedades Mitocondriales/metabolismo , Estrés Oxidativo
11.
Platelets ; 33(7): 1083-1089, 2022 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-35348041

RESUMEN

Platelets have an active energy metabolism mediated by mitochondria. However, the role of mitochondria in platelet adhesion, activation, and thrombus formation under blood flow conditions remains to be elucidated. Blood specimens were obtained from healthy adult volunteers. The consumption of glucose molecules by platelets was measured after 24 hours. Platelet adhesion, activation, and thrombus formation on collagen fibrils and immobilized von Willebrand factor (VWF) at a wall shear rate of 1,500 s-1 were detected by fluorescence microscopy with an ultrafast laser confocal unit in the presence or absence of mitochondrial functional inhibitors of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), antimycin A, and oligomycin. Consumption of glucose molecules within the first 24 h of 4.21 × 10-15 ± 4.46 x 10-15 (n = 6) increased to 13.82 × 10-15 ± 3.46 x 10-15 (n = 4) in the presence of FCCP, 12.11 × 10-15 ± 2.33 x 10-15 (n = 4) in the presence of antimycin A, and 11.87 × 10-15 ± 3.56 x 10-15 (n = 4) in the presence of oligomycin (p < .05). These mitochondrial functional blockers did not influence both surface area coverage by platelets and the 3-dimensional size of platelet thrombi formed on the collagen fibrils. However, a rapid increase in the intracellular calcium ion concentration ([Ca2+]i) upon adhering on immobilized VWF decreased significantly from 405.5 ± 86.2 nM in control to 198.0 ± 79.2 nM in the presence of FCCP (p < .005). A similar decrease in the rapid increase in ([Ca2+]i) was observed in the presence of antimycin A and oligomycin. Mitochondrial function is necessary for platelet activation represented by a rapid increase in [Ca2+]i after platelet adhesion on VWF. However, the influence could not be detected as changes in platelet adhesion or 3-dimensional growth of platelet thrombi on collagen fibrils.


Asunto(s)
Trombosis , Factor de von Willebrand , Adulto , Antimicina A/metabolismo , Antimicina A/farmacología , Plaquetas/metabolismo , Carbonil Cianuro p-Trifluorometoxifenil Hidrazona/metabolismo , Colágeno/metabolismo , Metabolismo Energético , Glucosa/metabolismo , Humanos , Mitocondrias/metabolismo , Oligomicinas/metabolismo , Oligomicinas/farmacología , Adhesividad Plaquetaria , Trombosis/metabolismo , Factor de von Willebrand/metabolismo
12.
Biochem J ; 479(1): 111-127, 2022 01 14.
Artículo en Inglés | MEDLINE | ID: mdl-34981811

RESUMEN

The cytochrome b6f complex (b6f) has been initially considered as the ferredoxin-plastoquinone reductase (FQR) during cyclic electron flow (CEF) with photosystem I that is inhibited by antimycin A (AA). The binding of AA to the b6f Qi-site is aggravated by heme-ci, which challenged the FQR function of b6f during CEF. Alternative models suggest that PROTON GRADIENT REGULATION5 (PGR5) is involved in a b6f-independent, AA-sensitive FQR. Here, we show in Chlamydomonas reinhardtii that the b6f is conditionally inhibited by AA in vivo and that the inhibition did not require PGR5. Instead, activation of the STT7 kinase upon anaerobic treatment induced the AA sensitivity of b6f which was absent from stt7-1. However, a lock in State 2 due to persisting phosphorylation in the phosphatase double mutant pph1;pbcp did not increase AA sensitivity of electron transfer. The latter required a redox poise, supporting the view that state transitions and CEF are not coercively coupled. This suggests that the b6f-interacting kinase is required for structure-function modulation of the Qi-site under CEF favoring conditions. We propose that PGR5 and STT7 independently sustain AA-sensitive FQR activity of the b6f. Accordingly, PGR5-mediated electron injection into an STT7-modulated Qi-site drives a Mitchellian Q cycle in CEF conditions.


Asunto(s)
Antimicina A/farmacología , Chlamydomonas reinhardtii/enzimología , Complejo de Citocromo b6f/metabolismo , Electrones , Proteínas Serina-Treonina Quinasas/metabolismo , Transducción de Señal/efectos de los fármacos , Tilacoides/enzimología , Antimicina A/metabolismo , Complejo de Citocromo b6f/antagonistas & inhibidores , Transporte de Electrón/efectos de los fármacos , Activación Enzimática , Ferredoxinas/metabolismo , Complejos de Proteína Captadores de Luz/metabolismo , Oxidación-Reducción , Oxidorreductasas actuantes sobre Donantes de Grupos Sulfuro/metabolismo , Fosforilación/efectos de los fármacos , Fotosíntesis/fisiología , Complejo de Proteína del Fotosistema I/metabolismo , Plastoquinona/metabolismo , Quinona Reductasas/metabolismo
13.
ACS Chem Biol ; 16(7): 1152-1158, 2021 07 16.
Artículo en Inglés | MEDLINE | ID: mdl-34151573

RESUMEN

Antimycins are anticancer compounds produced by a hybrid nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) pathway. The biosynthesis of these compounds is well characterized, with the exception of the standalone ß-ketoreductase enzyme AntM that is proposed to catalyze the reduction of the C8 carbonyl of the antimycin scaffold. Inactivation of antM and structural characterization suggested that rather than functioning as a post-PKS tailoring enzyme, AntM acts upon the terminal biosynthetic intermediate while it is tethered to the PKS acyl carrier protein. Mutational analysis identified two amino acid residues (Tyr185 and Phe223) that are proposed to serve as checkpoints controlling substrate access to the AntM active site. Aromatic checkpoint residues are conserved in uncharacterized standalone ß-ketoreductases, indicating that they may also act concomitantly with synthesis of the scaffold. These data provide novel mechanistic insights into the functionality of standalone ß-ketoreductases and will enable their reprogramming for combinatorial biosynthesis.


Asunto(s)
Oxidorreductasas de Alcohol/metabolismo , Antimicina A/análogos & derivados , Oxidorreductasas de Alcohol/química , Oxidorreductasas de Alcohol/genética , Secuencia de Aminoácidos , Antimicina A/biosíntesis , Antimicina A/metabolismo , Biocatálisis , Dominio Catalítico , Biología Computacional , Cristalografía por Rayos X , Simulación del Acoplamiento Molecular , Mutación , Unión Proteica , Alineación de Secuencia , Streptomyces/enzimología , Especificidad por Sustrato/genética
14.
Environ Toxicol ; 35(11): 1212-1224, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32662599

RESUMEN

The antibiotic antimycin A (AMA) is commonly used as an inhibitor for the electron transport chain but its application in anticancer studies is rare. Recently, the repurposing use of AMA in antiproliferation of several cancer cell types has been reported. However, it is rarely investigated in oral cancer cells. The purpose of this study is to investigate the selective antiproliferation ability of AMA treatment on oral cancer cells. Cell viability, flow cytometry, and western blotting were applied to explore its possible anticancer mechanism in terms of both concentration- and exposure time-effects. AMA shows the higher antiproliferation to two oral cancer CAL 27 and Ca9-22 cell lines than normal oral HGF-1 cell lines. Moreover, AMA induces the production of higher reactive oxygen species (ROS) levels and pan-caspase activation in oral cancer CAL 27 and Ca9-22 cells than in normal oral HGF-1 cells, providing the possible mechanism for its selective antiproliferation effect of AMA. In addition to ROS, AMA induces mitochondrial superoxide (MitoSOX) generation and depletes mitochondrial membrane potential (MitoMP). This further supports the AMA-induced oxidative stress changes in oral cancer CAL 27 and Ca9-22 cells. AMA also shows high expressions of annexin V in CAL 27 and Ca9-22 cells and cleaved forms of poly (ADP-ribose) polymerase (PARP), caspase 9, and caspase 3 in CAL 27 cells, supporting the apoptosis-inducing ability of AMA. Furthermore, AMA induces DNA damage (γH2AX and 8-oxo-2'-deoxyguanosine [8-oxodG]) in CAL 27 and Ca9-22 cells. Notably, the AMA-induced selective antiproliferation, oxidative stress, and DNA damage were partly prevented from N-acetylcysteine (NAC) pretreatments. Taken together, AMA selectively kills oral cancer cells in an oxidative stress-dependent mechanism involving apoptosis and DNA damage.


Asunto(s)
Antimicina A/farmacología , Antineoplásicos/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias de la Boca , Acetilcisteína/farmacología , Antimicina A/metabolismo , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Daño del ADN/efectos de los fármacos , Humanos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Poli(ADP-Ribosa) Polimerasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo
15.
Chem Commun (Camb) ; 55(63): 9379-9382, 2019 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-31317975

RESUMEN

Small-molecule natural products have been an essential source of pharmaceuticals to treat human diseases, but very little is known about their behavior inside dynamic, live human cells. Here, we demonstrate the first structure-activity-distribution relationship (SADR) study of complex natural products, the anti-cancer antimycin-type depsipeptides, using the emerging bioorthogonal Stimulated Raman Scattering (SRS) Microscopy. Our results show that the intracellular enrichment and distribution of these compounds are driven by their potency and specific protein targets, as well as the lipophilic nature of compounds.


Asunto(s)
Antimicina A/análogos & derivados , Antineoplásicos/química , Depsipéptidos/química , Antimicina A/química , Antimicina A/metabolismo , Antimicina A/farmacología , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Supervivencia Celular/efectos de los fármacos , Depsipéptidos/metabolismo , Depsipéptidos/farmacología , Células HeLa , Humanos , Células MCF-7 , Microscopía Fluorescente , Espectrometría Raman , Relación Estructura-Actividad
16.
Protoplasma ; 256(5): 1375-1383, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31079230

RESUMEN

In order to gain more insight into the involvement of mitochondrial complex III in the Cd-induced stress, we studied the effect of complex III inhibitors, antimycin A (AA), and myxothiazol (MYXO), on the Cd-induced ROS and NO generation in the barley root tip. Short-term exposure of barley roots to either MYXO or AA provoked a dose-dependent increase in both H2O2 and NO formation. In contrast to H2O2 generation, an enhanced superoxide formation in the transition zone of the root was a characteristic feature of AA-treated roots. MYXO and AA co-treatment had an additive effect on the amount of both H2O2 and NO formed in roots. On the other hand, AA-induced superoxide formation was markedly reversed in roots co-treated with MYXO. Both AA and MYXO exacerbated the Cd-mediated H2O2 or NO generation in the root tip. On the contrary, while AA also exacerbated the Cd-induced superoxide generation, MYXO dose-dependently attenuated it. These data provide strong evidence that ROS generation, a very early symptom of Cd toxicity in roots, is originated in mitochondria. Cd, similarly to AA, generates superoxide by blocking the mitochondrial electron transport chain (ETC) at complex III. In turn, the site of Cd-induced NO generation is not associated with complex III, but ROS formed in mitochondria at this third complex of ETC are probably responsible for enhanced NO generation in barley root under Cd stress.


Asunto(s)
Antimicina A/metabolismo , Cadmio/metabolismo , Hordeum/química , Peróxido de Hidrógeno/metabolismo , Óxido Nítrico/metabolismo , Raíces de Plantas/química , Superóxidos/metabolismo , Metacrilatos/metabolismo , Tiazoles/metabolismo
17.
FEMS Yeast Res ; 19(2)2019 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-30500899

RESUMEN

Scheffersomyces stipitis shows a high capacity to ferment xylose, with a strong oxygen dependence to allow NAD+ regeneration. However, without oxygen regeneration of NADH occurs by other metabolic pathways like alcoholic fermentation. There are few reports about inhibitors of mitochondrial respiration and their effects on growth and fermentation. This work aimed to explore the effect of cytochrome bc1 complex inhibition by antimycin A (AA), on growth and fermentation of S. stipitis using glucose, xylose and arabinose as carbon sources, at three agitation levels (0, 125 and 250 rpm). It was possible to discriminate between respiratory and fermentative metabolism in these different conditions using xylose or arabinose. Despite the inhibition of mitochondrial respiration, the glycolytic flux was active because S. stipitis metabolized glucose or xylose to produce ATP; on 0.5 M glucose the cells yielded 17-33 g L-1 ethanol. However, more complex results were obtained on xylose, which depended upon agitation conditions where ethanol production without agitation increased up to 11 g L-1. Inhibition of respiratory chain in S. stipitis could therefore be a good strategy to improve ethanol yields.


Asunto(s)
Arabinosa/metabolismo , Carbono/metabolismo , Complejo III de Transporte de Electrones/antagonistas & inhibidores , Glucosa/metabolismo , Saccharomycetales/crecimiento & desarrollo , Saccharomycetales/metabolismo , Xilosa/metabolismo , Antimicina A/metabolismo , Inhibidores Enzimáticos/metabolismo , Etanol/metabolismo , Fermentación/efectos de los fármacos , Glucólisis , Análisis de Flujos Metabólicos , Oxidación-Reducción , Saccharomycetales/efectos de los fármacos
18.
Nat Commun ; 9(1): 3534, 2018 08 30.
Artículo en Inglés | MEDLINE | ID: mdl-30166552

RESUMEN

Reprogramming of the NRPS/PKS assembly line is an attractive method for the production of new bioactive molecules. However, it is usually hampered by the loss of intimate domain/module interactions required for the precise control of chain transfer and elongation reactions. In this study, we first establish heterologous expression systems of the unique antimycin-type cyclic depsipeptides: JBIR-06 (tri-lactone) and neoantimycin (tetra-lactone), and engineer their biosyntheses by taking advantage of bioinformatic analyses and evolutionary insights. As a result, we successfully accomplish three manipulations: (i) ring contraction of neoantimycin (from tetra-lactone to tri-lactone), (ii) ring expansion of JBIR-06 (from tri-lactone to tetra-lactone), and (iii) alkyl chain diversification of JBIR-06 by the incorporation of various alkylmalonyl-CoA extender units, to generate a set of unnatural derivatives in practical yields. This study presents a useful strategy for engineering NRPS-PKS module enzymes, based on nature's diversification of the domain and module organizations.


Asunto(s)
Antimicina A/análogos & derivados , Familia de Multigenes/genética , Péptido Sintasas/metabolismo , Sintasas Poliquetidas/metabolismo , Secuencia de Aminoácidos , Antimicina A/metabolismo , Benzamidas/metabolismo , Biología Computacional , Evolución Molecular , Macrólidos/metabolismo , Datos de Secuencia Molecular , Complejos Multienzimáticos/metabolismo , Compuestos Orgánicos/metabolismo , Péptido Sintasas/química , Péptido Sintasas/genética , Sintasas Poliquetidas/química , Sintasas Poliquetidas/genética , Homología de Secuencia de Aminoácido , Especificidad por Sustrato
19.
PLoS One ; 13(5): e0198145, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29795673

RESUMEN

Sequencing of Streptomyces genomes has revealed they harbor a high number of biosynthesis gene cluster (BGC), which uncovered their enormous potentiality to encode specialized metabolites. However, these metabolites are not usually produced under standard laboratory conditions. In this manuscript we report the activation of BGCs for antimycins, carotenoids, germicidins and desferrioxamine compounds in Streptomyces argillaceus, and the identification of the encoded compounds. This was achieved by following different strategies, including changing the growth conditions, heterologous expression of the cluster and inactivating the adpAa or overexpressing the abrC3 global regulatory genes. In addition, three new carotenoid compounds have been identified.


Asunto(s)
Antimicina A/análogos & derivados , Carotenoides/metabolismo , Deferoxamina/metabolismo , Familia de Multigenes , Fenoles/metabolismo , Pironas/metabolismo , Streptomyces/genética , Streptomyces/metabolismo , Antimicina A/metabolismo , Regulación Bacteriana de la Expresión Génica , Streptomyces/crecimiento & desarrollo
20.
Biophys J ; 113(7): 1599-1612, 2017 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-28978450

RESUMEN

Ubiquinol cytochrome c oxidoreductase (bc1 complex) serves as an important electron junction in many respiratory systems. It funnels electrons coming from NADH and ubiquinol to cytochrome c, but it is also capable of producing significant amounts of the free radical superoxide. In situ and in other experimental systems, the enzyme exists as a dimer. But until recently, it was believed to operate as a functional monomer. Here we show that a functional dimer model is capable of explaining both kinetic and superoxide production rate data. The model consists of six electronic states characterized by the number of electrons deposited on the complex. It is fully reversible and strictly adheres to the thermodynamics governing the reactions. A total of nine independent data sets were used to parameterize the model. To explain the data with a consistent set of parameters, it was necessary to incorporate intramonomer Coulombic effects between hemes bL and bH and intermonomer Coulombic effects between bL hemes. The fitted repulsion energies fall within the theoretical range of electrostatic calculations. In addition, model analysis demonstrates that the Q pool is mostly oxidized under normal physiological operation but can switch to a more reduced state when reverse electron transport conditions are in place.


Asunto(s)
Complejo III de Transporte de Electrones/metabolismo , Modelos Moleculares , Animales , Antimicina A/metabolismo , Simulación por Computador , Citocromos c/metabolismo , Complejo III de Transporte de Electrones/química , Cinética , Liposomas/metabolismo , Mitocondrias/metabolismo , Multimerización de Proteína , Superóxidos/metabolismo , Termodinámica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA